載入...
Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic condition involving the inflammation of the colon and small intestine. IBD affects as many as 1.4 million people in the U.S. alone and costs the health care industry over $1.7 billion annually. Managing IBD normally requires invasive and often discomfort...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5332167/ https://ncbi.nlm.nih.gov/pubmed/28286723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1004 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|